Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	54.69	235.32	152.12
Graham Fair Price	11.53	13.24	11.87
PEG	1474.59	3.44	-0.22
Price/Book	30.40	5.72	4.39
Price/Cash Flow	-31.82	-136.31	-103.40
Prices/Earnings	9.93	75.23	68.44
Price/Sales	28.70	25.01	19.43
Price/FCF	-31.82	-136.31	-103.40
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	19.08	0.39	0.33
Operating Margin	-44.80	0.04	0.07
ROA	20.33	0.01	0.01
ROE	0.02	0.02	18.63
ROIC	0.01	< 0.005	-46.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-150.37
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	3.12	-0.43	-86.32
EPS QOQ	3.13	0.22	-93.02
FCF QOQ	-1.03	-0.01	98.59
Revenue QOQ	0.07	0.04	-46.96
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	39.15	47.14	20.43
Days Sales Outstanding (DSO)	23.71	27.54	16.16
Inventory Turnover	2.30	1.91	-16.96
Debt/Capitalization	0.29	0.29	-1.71
Quick Ratio	3.96	3.98	0.50
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	19.76	20.24	2.40
Cash	6.15	5.34	-13.27
Capex	-1.61	-0.96	40.09
Free Cash Flow	-0.84	-0.85	-1.29
Revenue	4.47	4.63	3.75
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.79	4.97	3.69
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.52	6.78	49.99
Naive Interpretation	Member

06 - Financial Health · Bad

Rating